Rapid detection of rpoB gene mutations conferring rifampin resistance in Mycobacterium tuberculosis

Journal of Clinical Microbiology

Volumn 50, Issue 7, 2012, Pages 2433-2440

  Ao, Wanyuan ^a   Aldous, Stephen ^a   Woodruff, Evelyn ^a   Hicke, Brian ^a   Rea, Larry ^a   Kreiswirth, Barry ^b   Jenison, Robert ^a  

^a Great Basin Corporation   (United States)

^b PUBLIC HEALTH RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; RIFAMPICIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CODON; CONTROLLED STUDY; DNA TEMPLATE; GENE; GENE AMPLIFICATION; GENE MUTATION; GENE SEQUENCE; GENE TARGETING; MUTATIONAL ANALYSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; POINT MUTATION; PRIORITY JOURNAL; RPOB GENE;

ANTITUBERCULAR AGENTS; BACTERIAL PROTEINS; HUMANS; MICROBIAL SENSITIVITY TESTS; MUTATION, MISSENSE; MYCOBACTERIUM TUBERCULOSIS; NUCLEIC ACID AMPLIFICATION TECHNIQUES; RIFAMPIN; SENSITIVITY AND SPECIFICITY;

EID: 84862727038     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00208-12     Document Type: Article

References (44)

1. Ajbani K, Shetty A, Mehta A, Rodrigues C. 2011. Rapid diagnosis of extensively drug-resistant tuberculosis by use of reverse line blot hybridization assay. J. Clin. Microbiol. 49:2546-2551.
2. An L, et al. 2005. Characterization of a thermostable UvrD helicase and its participation in helicase-dependent amplification. J. Biol. Chem. 280: 28952-28958.
3. Bártfai Z, et al. 2001. Molecular characterization of rifampin-resistant isolates of Mycobacterium tuberculosis from Hungary by DNA sequencing and the line probe assay. J. Clin. Microbiol. 39:3736-3769.
4. Becerra MC, et al. 2010. Recurrence after treatment for pulmonary multidrug- resistant tuberculosis. Clin. Infect. Dis. 51:709-711.
5. Blakemore R, et al. 2010. Evaluation of the analytical performance of the Xpert MTB/RIF assay. J. Clin. Microbiol. 48:2495-2501.
6. Boehme CC, et al. 2010. Rapid molecular detection of tuberculosis and rifampin resistance. N. Engl. J. Med. 363:1005-1015.
7. Caws M, et al. 2006. Mutations prevalent among rifampin- and isoniazid-resistant Mycobacterium tuberculosis isolates from a hospital in Vietnam. J. Clin. Microbiol. 44:2333-2337.
8. Chan RC, et al. 2007. Genetic and phenotypic characterization of drugresistant Mycobacterium tuberculosis isolates in Hong Kong. J. Antimicrob. Chemother. 59:866-873.
9. Denys GA, Renzi PB, Wissel CM, Koch KM. 2011. Portrait Staph ID/R: a novel molecular diagnostic test for simultaneous identification of Staphylococcus species and detection of the mecA gene directly from positive blood cultures, abstr 40-D. Abstr. 2nd ASMET Conf. American Society for Microbiology, Washington, DC.
10. Dobosy JR, et al. 2011. RNase H-dependent PCR (rhPCR): improved specificity and single nucleotide polymorphism detection using blocked cleavable primers. BMC Biotechnol. 11:80. doi:10.1186/1472-6750-11-80.
11. Gerber MA, et al. 1997. Optical immunoassay for group A β-hemolytic streptococcal pharyngitis: an office-based, multicenter investigation. JAMA 277:899-903.
12. Heep M, et al. 2001. Frequency of rpoB mutations inside and outside the cluster I region in rifampin-resistant clinical Mycobacterium tuberculosis isolates. J. Clin. Microbiol. 39:107-110.
13. Helb D, et al. 2010. Rapid detection of Mycobacterium tuberculosis and rifampin resistance by use of on-demand, near-patient technology. J. Clin.Microbiol. 48:229-237.
14. Herrera L, Jiménez S, Valverde A, GarcíA-Aranda MA, Sáez-Nieto JA. 2003. Molecular analysis of rifampin-resistant Mycobacterium tuberculosis isolated in Spain (1996-2001). Description of new mutations in the rpoB gene and review of the literature. Int. J. Antimicrob.Agents 21:403-408.
15. Hillemann D, Weizenegger M, Kubica T, Richter E, Niemann S. 2005.Use of the genotype MTBDR assay for rapid detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis complex isolates. J.Clin. Microbiol. 43:3699-3703.
16. Huang H, Jin Q, Ma Y, Chen X, Zhuang Y. 2002. Characterization of rpoB mutations in rifampin-resistant Mycobacterium tuberculosis isolated in China. Tuberculosis (Edinb.) 82:79-83.
17. Iwamoto T, Sonobe T, Hayashi K. 2003. Loop-mediated isothermal amplification for direct detection of Mycobacterium tuberculosis complex,M. avium, and M. intracellulare in sputum samples. J. Clin. Microbiol.41:2616-2622.
18. Jenison R, Yang S, Haeberli A, Polisky B. 2001. Interference-based detection of nucleic acid targets on optically coated silicon. Nat. Biotechnol.19:62-65.
19. Jenison R, La H, Haeberli A, Ostroff R, Polisky B. 2001. Silicon-based biosensors for rapid detection of protein or nucleic acid targets. Clin.Chem. 47:1894-1900.
20. Kapur V, et al. 1995. Rapid Mycobacterium species assignment and unambiguous identification of mutations associated with antimicrobial resistance in Mycobacterium tuberculosis by automated DNA sequencing.Arch. Pathol. Lab. Med. 119:131-138.
21. Kapur V, et al. 1994. Characterization by automated DNA sequencing of mutations in the gene (rpoB) encoding the RNA polymerase beta subunit in rifampin-resistant Mycobacterium tuberculosis strains from New York City and Texas. J. Clin. Microbiol. 32:1095-1098.
22. Kollef MH, Sherman G, Ward S, Fraser VJ. 1999. Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest 115:462-474.
23. Lipin MY, Stepanshina VN, Shemyakin IG, Shinnick TM. 2007. Association of specific mutations in katG, rpoB, rpsL and rrs genes with spoligotypes of multidrug-resistant Mycobacterium tuberculosis isolates in Russia.Clin. Microbiol. Infect. 13:620-626.
24. Mani C, Selvakumar N, Narayanan S, Narayanan PR. 2001. Mutations in the rpoB gene of multidrug-resistant Mycobacterium tuberculosis clinical isolates from India. J. Clin. Microbiol. 39:2987-2990.
25. Mani C, Selvakumar N, Kumar V, Narayanan S, Narayanan PR. 2003.Comparison of DNA sequencing, PCR-SSCP and PhaB assays with indirect sensitivity testing for detection of rifampin resistance in Mycobacterium tuberculosis. Int. J. Tuberc. Lung Dis. 7:652-659.
26. Millen SJ, Uys PW, Hargrove J, van Helden PD, Williams BG. 2008. The effect of diagnostic delays on the drop-out rate and the total delay to diagnosis of tuberculosis. PLoS One 3:e1933. doi:10.1371/journal.pone.0001933.
27. Miller LP, Crawford JT, Shinnick TM. 1994. The rpoB gene of Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 38:805-811.
28. Mitnick CD, Appeton SC, Shin SS. 2008. Epidemiology and treatment of multidrug resistant tuberculosis. Semin. Respir. Crit. Care Med. 29:499-524.
29. Mitnick CD, et al. 2008. Comprehensive treatment of extensively drugresistant tuberculosis. N. Engl. J. Med. 359:563-574.
30. Nahid P, Pai M, Hopewell PC. 2006. Advances in the diagnostics and treatment of tuberculosis. Proc. Am. Thorac. Soc. 3:103-110.
31. Noordhoek GT, van Embden JD, Kolk AH. 1996. Reliability of nucleic acid amplification for detection of Mycobacterium tuberculosis: an international collaborative quality control study among 30 laboratories. J. Clin.Microbiol. 34:2522-2525.
32. Pai M, Kalantri S, Dheda K. 2006. New tools and emerging technologies for the diagnosis of tuberculosis. Part II. Active tuberculosis and drug resistance. Expert Rev. Mol. Diagn. 6:423-432.
33. Perkins MD, Cunningham J. 2007. Facing the crisis: improving the diagnosis of tuberculosis in the HIV era. J. Infect. Dis. 196:S15-S27.
34. Rossau R, et al. 1997. Evaluation of the INNO-LiPA Rif. TB assay, a reverse hybridization assay for the simultaneous detection of Mycobacterium tuberculosis complex and its resistance to rifampin. Antimicrob.Agents Chemother. 41:2093-2098.
35. Sajduda A, et al. 2004. Molecular characterization of rifampin- and isoniazid-resistant Mycobacterium tuberculosis strains isolated in Poland. J.Clin. Microbiol. 42:2425-2431.
36. Schutz E, von Ahsen N. 1999. Spreadsheet software for the thermodynamic melting point prediction of oligonucleotide hybridization with and without mismatches. Biotechniques 27:1218-1224.
37. Suffys P, et al. 2000. Evaluation of the polymerase chain reaction for the detection of Mycobacterium tuberculosis. Int. J. Tuberc. Lung Dis. 4:179-183.
38. Telenti A, et al. 1993. Detection of rifampin-resistance mutations in Mycobacterium tuberculosis. Lancet 341:647-650.
39. Telzak EE, et al. 1995. Multidrug-resistant tuberculosis in patients without HIV infection. N. Engl. J. Med. 333:907-911.
40. Urdea M, et al. 2006. Requirements for high impact diagnostics in the developing world. Nature 444:73-79.
41. von Ahsen N, Oellerich VW, Armstrong VW, Schutz E. 1999. Application of thermodynamic nearest neighbor mode to estimate nucleic acid stability and optimize probe design: prediction of melting points of different mutations of apolipoprotein B 3500 and factor V Leiden with a hybridization probe genotyping assay in the LightCycler. Clin. Chem. 45: 2094-2101.
42. World Health Organization. 2008. Anti-tuberculosis drug resistance in the world: fourth global report. The WHO/IUATLD Global Project on Anti-Tuberculosis Drug Resistance Surveillance. Publication no. WHO/ HTM/TB/2008.394. World Health Organization, Geneva, Switzerland.
43. Yang B, et al. 1998. Relationship between antimycobacterial activities of rifampin, rifabutin and KRM-1648 and rpoB mutations of Mycobacterium tuberculosis. J. Antimicrob. Chemother. 42:621-628.
44. Zhong XB, et al. 2003. Single-nucleotide polymorphism genotyping on optical thin-film biosensor chips. Proc. Natl. Acad. Sci. U. S. A. 100: 11559-11564.